Cigna Corporation +

Company

Ticker

UNH

CVS

Headquarter

Bloomfield ,CT

Minnetonka ,MN

Woonsocket ,RI

CEO

Mr. David Michael Cordani

Sir Andrew Philip Witty

Mr. J. David Joyner CEBS

Industry

Medical - Healthcare Plans

Stock Price

Market Cap

$92.19 B

$376.35 B

$84.21 B

Employees

Years

2022
2023
2024

2021
2022
2024

2022
2023
2024

Employees

71.30 K
72.50 K
73.50 K

350.00 K
400.00 K
400.00 K

300.00 K
300.00 K
300.00 K

Y/Y

3.26%

1.68%

1.38%

6.06%

14.29%

Revenue Per Employee

Years

2022
2023
2024

2021
2022
2024

2022
2023
2024

Revenue Per Employee

$2.52 M
$2.69 M
$3.32 M

$815.07 K
$805.33 K
$1.00 M

$1.07 M
$1.19 M
$1.24 M

Y/Y

6.78%

6.62%

23.5%

5.22%

1.19%

24.26%

10.39%

10.95%

4.2%

Net Income Per Employee

Years

2022
2023
2024

2021
2022
2024

2022
2023
2024

Net Income Per Employee

$94.03 K
$71.23 K
$46.72 K

$49.39 K
$50.30 K
$36.01 K

$14.37 K
$27.81 K
$15.38 K

Y/Y

29.04%

24.25%

34.41%

5.81%

1.85%

28.4%

46.12%

93.55%

44.7%

Income Statement

Revenue

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Revenue

$180.03 B
$195.19 B
$244.38 B

$322.13 B
$367.53 B
$400.28 B

$322.47 B
$357.78 B
$372.81 B

Y/Y

3.31%

8.42%

25.21%

12.92%

14.09%

8.91%

10.39%

10.95%

4.2%

Revenue by Products / Services

Revenue by Geography

Research and Development

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Research and Development

Y/Y

Operating Income

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Operating Income

$8.45 B
$8.54 B
$5.27 B

$28.44 B
$32.36 B
$32.29 B

$7.95 B
$13.74 B
$8.52 B

Y/Y

6.41%

1.02%

38.27%

18.63%

13.8%

0.22%

40.24%

72.78%

38.03%

Tax Rate (%)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Tax Rate (%)

19.00%
3.00%
28.00%

22.00%
21.00%
24.00%

26.00%
25.00%
25.00%

Y/Y

4.71%

86.69%

1005.47%

5.51%

5.31%

17.37%

6.95%

2.9%

1.19%

Net Income

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Net Income

$6.70 B
$5.16 B
$3.43 B

$20.12 B
$22.38 B
$14.41 B

$4.31 B
$8.34 B
$4.61 B

Y/Y

24.84%

22.97%

33.5%

16.4%

11.24%

35.64%

46.12%

93.55%

44.7%

Assets & Liabilities | Cash Flow

Total Assets

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Total Assets

$143.93 B
$152.76 B
$155.88 B

$245.71 B
$273.72 B
$298.28 B

$228.28 B
$249.73 B
$253.22 B

Y/Y

7.07%

6.13%

2.04%

15.79%

11.4%

8.97%

2.03%

9.4%

1.4%

Total Liabilities

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Total Liabilities

$98.98 B
$106.41 B
$114.64 B

$159.36 B
$174.80 B
$195.69 B

$156.51 B
$173.09 B
$177.49 B

Y/Y

8.1%

7.51%

7.73%

17.41%

9.69%

11.95%

0.71%

10.6%

2.54%

Capital Expenditures (Capex)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Capital Expenditures (Capex)

-$1.30 B
-$1.57 B
-$1.41 B

-$2.80 B
-$3.39 B
-$3.50 B

-$2.73 B
-$3.03 B
-$2.78 B

Y/Y

12.22%

21.47%

10.62%

14.18%

20.84%

3.34%

8.21%

11.15%

8.25%

Profitability

Operating Income Margin (%)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Operating Income Margin (%)

4.69%
4.37%
2.16%

8.83%
8.80%
8.07%

2.47%
3.84%
2.28%

Y/Y

2.85%

6.82%

50.57%

5.12%

0.34%

8.3%

45.83%

55.47%

40.63%

Net Income Margin (%)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Net Income Margin (%)

3.72%
2.65%
1.41%

6.25%
6.09%
3.60%

1.34%
2.33%
1.24%

Y/Y

20.78%

28.76%

46.79%

3.14%

2.56%

40.89%

51.09%

73.88%

46.78%

EBITDA

2021	10413000000.00
2022	12908000000.00
2023	9574000000.00
2024	9479000000.00

2021	27073000000.00
2022	31835000000.00
2023	32517000000.00
2024	9769000000.00

2021	17526000000.00
2022	12347000000.00
2023	18197000000.00
2024	13683000000.00

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

EBITDA

$12.91 B
$9.57 B
$9.48 B

$31.84 B
$32.52 B
$9.77 B

$12.35 B
$18.20 B
$13.68 B

Y/Y

23.96%

25.83%

0.99%

17.59%

2.14%

69.96%

29.55%

47.38%

24.81%

Free Cash Flow (FCF)

2021	6037000000.00
2022	7361000000.00
2023	10240000000.00
2024	8957000000.00

2021	19889000000.00
2022	23404000000.00
2023	25682000000.00
2024	20705000000.00

2021	15745000000.00
2022	13450000000.00
2023	10395000000.00
2024	6326000000.00

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Free Cash Flow (FCF)

$7.36 B
$10.24 B
$8.96 B

$23.40 B
$25.68 B
$20.71 B

$13.45 B
$10.40 B
$6.33 B

Y/Y

21.93%

39.11%

12.53%

17.67%

9.73%

19.38%

14.58%

22.71%

39.14%

Ratios

Return on Equity (ROE)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Return on Equity (ROE)

14.94%
11.17%
8.37%

25.87%
25.22%
15.55%

6.03%
10.91%
6.11%

Y/Y

31.05%

25.23%

25.07%

7.39%

2.51%

38.34%

43.43%

80.93%

44%

Return on Assets (ROA)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Return on Assets (ROA)

4.66%
3.38%
2.20%

8.19%
8.18%
4.83%

1.89%
3.34%
1.82%

Y/Y

34.29%

27.47%

34.91%

0.49%

0.12%

40.95%

44.9%

76.72%

45.51%

Debt to Equity

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Debt to Equity

69.29%
66.91%
77.92%

74.09%
70.46%
83.00%

98.97%
103.82%
109.74%

Y/Y

3.05%

3.43%

16.45%

15.57%

4.9%

17.8%

2.23%

4.9%

5.7%

Valuation

Enterprise Value

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Enterprise value

$128.90 B
$111.11 B
$101.82 B

$529.45 B
$525.67 B
$521.54 B

$180.05 B
$172.65 B
$130.85 B

Y/Y

21.38%

13.8%

8.36%

6.28%

0.71%

0.79%

11.16%

4.11%

24.21%

Enterprise value to Revenue

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Enterprise value to Revenue

0.72
0.57
0.42

1.64
1.43
1.30

0.56
0.48
0.35

Y/Y

17.49%

20.49%

26.82%

5.88%

12.98%

8.91%

19.52%

13.57%

27.27%

Enterprise value to EBITDA

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Enterprise value to EBITDA

9.99
11.61
10.74

16.63
16.17
53.39

14.58
9.49
9.56

Y/Y

2.08%

16.22%

7.44%

9.62%

2.79%

230.24%

26.11%

34.94%

0.79%

Cigna Corporation Competitors & Alternatives

Income Statement

Assets & Liabilities | Cash Flow

Profitability

Ratios

Valuation

Related company

Submit feedback to Bullfincher